BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38013514)

  • 1. Proton pump inhibitors: Weighing the benefits and risks across various health conditions.
    Sizgoric L; Likic R
    Br J Clin Pharmacol; 2024 Feb; 90(2):388-391. PubMed ID: 38013514
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Proton Pump Inhibitors and risk of gastric cancer.
    Karakan T
    Turk J Gastroenterol; 2018 Jan; 29(1):143-144. PubMed ID: 29391326
    [No Abstract]   [Full Text] [Related]  

  • 4. Pantoprazole, Prout and the proton pump.
    Playford RJ; Podas T; Modlin I
    Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
    Devault KR
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New-generation proton pump inhibitors: progress in the treatment of peptic acid diseases?].
    de Korwin JD; Ducrotté P; Vallot T
    Presse Med; 2004 Jun; 33(11):746-54. PubMed ID: 15257232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors in children: a review.
    Marchetti F; Gerarduzzi T; Ventura A
    Dig Liver Dis; 2003 Oct; 35(10):738-46. PubMed ID: 14620626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton-pump inhibitors for gastric acid-related disease.
    Franko TG; Richter JE
    Cleve Clin J Med; 1998 Jan; 65(1):27-34. PubMed ID: 9465453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of proton pump inhibitors and risks of gastric cancer.
    Zeng R; Sha W; Wang J; Zhuo Z; Wu H; Leung FW; Chen H
    Gut; 2022 Sep; 71(9):1924-1926. PubMed ID: 34836917
    [No Abstract]   [Full Text] [Related]  

  • 10. [All proton pump inhibitors are equally efficacious in standard dosages].
    Hellström PM; Vitols S
    Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
    Horn J
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proton pump inhibitors and non-prescription].
    Gellerfors M
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):14. PubMed ID: 20094114
    [No Abstract]   [Full Text] [Related]  

  • 13. Barrett's esophagus: acid suppression, but no regression.
    Bozymski EM; Shaheen NJ
    Am J Gastroenterol; 1997 Apr; 92(4):556-8. PubMed ID: 9128299
    [No Abstract]   [Full Text] [Related]  

  • 14. Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
    Metz DC; Ferron GM; Paul J; Turner MB; Soffer E; Pisegna JR; Bochenek WJ
    J Clin Pharmacol; 2002 May; 42(5):512-9. PubMed ID: 12017345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?
    Yeomans ND; Dent J
    Aliment Pharmacol Ther; 2000 Mar; 14(3):267-71. PubMed ID: 10735918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of proton pump inhibitors].
    Herszényi L; Tulassay Z
    Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
    Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
    Nzeako UC; Murray JA
    Aliment Pharmacol Ther; 2002 Jul; 16(7):1309-16. PubMed ID: 12144581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis or rupture: duration of acid inhibition by proton pump inhibitors.
    Sachs G; Shin JM; Pratha V; Hogan D
    Drugs Today (Barc); 2003 Mar; 39 Suppl A():11-4. PubMed ID: 12712216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication increases nocturnal acid breakthrough.
    van Herwaarden MA; Samsom M; Smout AJ
    Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.